Form 4: OrbiMed Advisors Sells 1,781 Shares of NeuroPace Inc (NPCE)

OrbiMed Advisors LLC reports the sale of 1,781 shares of NeuroPace Inc (NPCE) at $14.06 per share on April 24, 2024, while still indirectly holding a significant number of shares.

Summary

• OrbiMed Advisors LLC, along with OrbiMed Capital GP VI LLC, filed a Form 4 detailing changes in beneficial ownership of NeuroPace Inc (NPCE) stock.
• On April 24, 2024, OrbiMed Advisors sold 1,781 shares of common stock at a price of $14.06 per share.
• Following the transaction, OrbiMed Advisors indirectly owns 3,435,541 shares through OrbiMed Private Investments VI, LP (OPI VI).
• OrbiMed Capital GP VI LLC is the general partner of OPI VI, and OrbiMed Advisors LLC is the managing member of GP VI.
• Both OrbiMed Advisors and GP VI disclaim beneficial ownership of the securities, except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard disclosure of stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell shares. This filing indicates a change in OrbiMed's holdings in NeuroPace, which could be of interest to other investors.

Stakeholder Impact

• The sale of shares by a major shareholder like OrbiMed Advisors could potentially influence investor sentiment and the stock price of NeuroPace Inc.

Key Dates